RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Douglas M. Watts to Viral Vaccines

This is a "connection" page, showing publications Douglas M. Watts has written about Viral Vaccines.
Connection Strength

2.584
  1. Watts DM, Westover JLB, Palermo PM, Bailey KW, Morrill JC, Bettinger GE, Monath TP, Smith DR, Peters CJ, Pittman PR, Orbegozo J, Gowen BB. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.
    View in: PubMed
    Score: 0.843
  2. Nyundo S, Adamson E, Rowland J, Palermo PM, Matiko M, Bettinger GE, Wambura P, Morrill JC, Watts DM. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12?NSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania. Onderstepoort J Vet Res. 2019 Jan 31; 86(1):e1-e8.
    View in: PubMed
    Score: 0.656
  3. Siirin MT, Travassos da Rosa AP, Newman P, Weeks-Levy C, Coller BA, Xiao SY, Lieberman MM, Watts DM. Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters. Am J Trop Med Hyg. 2008 Dec; 79(6):955-62.
    View in: PubMed
    Score: 0.324
  4. Watts DM, Tesh RB, Siirin M, Rosa AT, Newman PC, Clements DE, Ogata S, Coller BA, Weeks-Levy C, Lieberman MM. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine. 2007 Apr 12; 25(15):2913-8.
    View in: PubMed
    Score: 0.277
  5. Bamouh Z, Hamdi J, Elkarhat Z, Fellahi S, Omari Tadlaoui K, Watts DM, Fassi Fihri O, Elharrak M. Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus. Vaccine. 2022 10 26; 40(45):6471-6480.
    View in: PubMed
    Score: 0.211
  6. Xu W, Watts DM, Costanzo MC, Tang X, Venegas LA, Jiao F, Sette A, Sidney J, Sewell AK, Wooldridge L, Makino S, Morrill JC, Peters CJ, Kan-Mitchell J. The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses. PLoS One. 2013; 8(3):e59210.
    View in: PubMed
    Score: 0.109
  7. Lokugamage KG, Yoshikawa-Iwata N, Ito N, Watts DM, Wyde PR, Wang N, Newman P, Kent Tseng CT, Peters CJ, Makino S. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine. 2008 Feb 06; 26(6):797-808.
    View in: PubMed
    Score: 0.076
  8. Lieberman MM, Clements DE, Ogata S, Wang G, Corpuz G, Wong T, Martyak T, Gilson L, Coller BA, Leung J, Watts DM, Tesh RB, Siirin M, Travassos da Rosa A, Humphreys T, Weeks-Levy C. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine. 2007 Jan 05; 25(3):414-23.
    View in: PubMed
    Score: 0.069
  9. Arrigo NC, Watts DM, Frolov I, Weaver SC. Experimental infection of Aedes sollicitans and Aedes taeniorhynchus with two chimeric Sindbis/Eastern equine encephalitis virus vaccine candidates. Am J Trop Med Hyg. 2008 Jan; 78(1):93-7.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support